SteadySkin
Choose a condition

Switch what the shared guides emphasize.

VitiligoPsoriasisNot sure yet
AppMy next conversationSaved
Freshness and correctionsWhat this means, what you can do, and what to ask next.

What's new at SteadySkin

This site is maintained, not frozen. See what changed, when facts were checked, and where each update came from.

Written and sourced by Ajith Dhati, a patient—not a clinician. No named clinical reviewer is attached. Read the editorial policy.

Last updated

Recent changes

  1. vitiligoProgram change

    Europe’s CHMP issued a positive opinion for Rinvoq (upadacitinib) in nonsegmental vitiligo. This is not an approval; the European Commission decision is pending.

    Evidence · 1 source
    • European Medicines Agency — CHMP positive opinion and pending European Commission decision. Source dated or checked . Confidence: high.

  2. vitiligoResearch

    Incyte reported that its Phase 3 povorcitinib vitiligo studies met their main goal and said future regulatory applications are planned.

    Evidence · 1 source
    • Incyte — Sponsor-reported Phase 3 result and planned regulatory applications. Source dated or checked . Confidence: moderate.

  3. vitiligoProgram change

    AbbVie reported FDA and EMA submissions for Rinvoq (upadacitinib) in nonsegmental vitiligo. It remains unapproved for vitiligo.

    Evidence · 1 source
    • AbbVie — FDA and EMA submissions for a vitiligo indication. Source dated or checked . Confidence: moderate.

Follow updates by RSS

Get new guide alerts

One short email when SteadySkin adds a meaningful guide or records a major treatment-status change. This is not the app launch waitlist and not a general newsletter.

Email alerts are not collecting addresses in this build. The RSS feed is available now.

How to read an update

A useful change log says what changed, when it changed, and where to confirm it.

  • Check the date and condition tag.
  • Open the source when the update may affect a decision.
  • Use the correction link if a page no longer matches its source.
  • Ask your care team before changing treatment because of an update.

New guide alerts are separate from the app waitlist

Guide alerts have one promise: a short message when a meaningful site guide changes.

They are not the app waitlist and do not enroll you in app news. The sign-up should appear only when its own delivery and privacy settings are ready.

What you can do if something looks old

You should not have to guess whether an undated fact is still current.

Open the linked source, compare its date with the page stamp, and send a correction if they no longer agree. Until it is checked, do not use the page alone for a care decision.

What to say to your doctor or care team

Use these words as written, or change them to fit what you need.

  • Has this update changed what is available for me now?Saving keeps this on your device and needs JavaScript, which is off in this browser.
  • Which original source should I read before making a decision?Saving keeps this on your device and needs JavaScript, which is off in this browser.
  • Does this news change my current plan, or can my plan stay the same?Saving keeps this on your device and needs JavaScript, which is off in this browser.